Brief: Datrix Joins Project To Fight Antibiotic Resistance With Artificial Intelligence
Nov 3 (Reuters) - Datrix SpA DATR.MI: JOINS LOMBARDY'S REGION ARTIBAC PROJECT TO FIGHT ANTIBIOTIC RESISTANCE WITH ARTIFICIAL INTELLIGENCE VALUED AT ABOUT €7 MILLION, AWARDED TO A MULTIDISCIPLINARY CONSORTIUM OF SCIENTIFIC, CLINICAL, TECHNOLOGICAL EXCELLENCE PROJECT AIMS TO DEVELOP NEW THERAPEUTIC STRATEGIES TO COMBAT ANTIBIOTIC RESISTANCE Further company coverage: DATR.MI (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Datrix SpA
See all newsBrief: Datrix Says Aramix, KLN Project Sign Three-Year Partnership For Advanced AI Solutions
Brief: Datrix Unit Navla To Support Volkswagen's Digital Search Strategy
Brief: L'Oréal Italia Renews Three-Year Collaboration With Datrix's Navla
Brief: Datrix FY Net Loss EUR 2.1 Mln
Brief: Datrix Shareholder BNP Paribas AM Exceeds 5% Threshold